There are currently varying levels of evidence for currently utilized strategies for dabigatran reversal for immenent risk of death or major bleeding. I was hoping that the authors and experts would be able to discuss the evidence and their experience with treatments like fresh frozen plasma & apcc or aminocaproic acid? What do you imagine the role for these therapies will be if idarucizumab is approved?
Charles Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FCPP
Associate Provost for Innovation in Education at Thomas Jefferson University
Heather Laird-Fick, MD, MPH
Associate Professor of Medicine at Michigan State University College of Human Medicine
Rohan Jotwani, MD/MBA Candidate
MD/MBA Candidate at the Tufts School of Medicine
- All Questions & Answers
- Question: Alternative strategies for dabigatran reversal?
Time Zone: EST